Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.61 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.61 |
| ▸ | ABAT | P80404 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.61 |
| ▸ | FDPS | P14324 | 1/20 | 0.58 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.56 |
| ▸ | TTR | P02766 | 1/20 | 0.53 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.51 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.51 |
| ▸ | BACE1 | P56817 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL435689 | 0.84 | ALDH1A1 (0.68) | ALDH1A1TSHRHPGDTRIM24ALDH5A1 | |
| SCHEMBL29400600 | 0.84 | ALDH1A1 (0.68) | ALDH1A1TSHRHPGDTRIM24ALDH5A1 | |
| SCHEMBL7531959 | 0.84 | ALDH1A1 (0.68) | ALDH1A1TSHRHPGDTRIM24ALDH5A1 | |
| SCHEMBL9995594 | 0.82 | XDH (0.66) | ALDH1A1TSHRAMY1ABACE1MAPT | |
| SCHEMBL9995756 | 0.82 | XDH (0.66) | ALDH1A1TSHRAMY1ABACE1MAPT | |
| SCHEMBL12495481 | 0.82 | AMY1A (0.53) | ALDH1A1TSHRAMY1ABACE1MAPT | |
| 3,4-Dimethoxybenzaldehyde SCHEMBL25202 | 0.81 | ALDH1A1 (1.00) | ALDH1A1TSHRHPGDTRIM24ALDH5A1 | |
| 3,4-Dimethoxybenzaldehyde SCHEMBL5308959 | 0.81 | ALDH1A1 (1.00) | ALDH1A1TSHRHPGDTRIM24ALDH5A1 | |
| 3,4-Dimethoxybenzaldehyde SCHEMBL1330962 | 0.81 | ALDH1A1 (1.00) | ALDH1A1TSHRHPGDTRIM24ALDH5A1 | |
| 3,4-Dimethoxybenzaldehyde SCHEMBL29364994 | 0.81 | ALDH1A1 (1.00) | ALDH1A1TSHRHPGDTRIM24ALDH5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1029 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116120182-A | Curcumin derivative, synthesis method thereof and application thereof in antiandrogen receptor | 常州大学 | 2023-05-16 | — | — | CN | claimed |
| CN-112299967-B | Preparation method of 3-methoxy-4-fluorobenzaldehyde | 无锡双启科技有限公司 | 2022-04-08 | — | — | CN | claimed |
| CN-112299967-A | Preparation method of 3-methoxy-4-fluorobenzaldehyde | 无锡双启科技有限公司 | 2021-02-02 | — | — | CN | claimed |
| CN-121990985-A | Double-response small molecule fluorescent probe for synchronously detecting NTR and nucleic acid and preparation and application thereof | 安徽医科大学 | 2026-05-08 | — | — | CN | disclosed |
| EP-4735425-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2026-05-06 | — | — | EP | disclosed |
| US-20260092059-A1 | Broad Spectrum Antiviral Compositions and Methods | EVRYS BIO, LLC (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4359402-B1 | IMIDAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORS | THERAVANCE BIOPHARMA R&D IP LLC (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4704846-A2 | NOVEL ERGOLINES AND METHODS OF TREATING MOOD DISORDERS | Gilgamesh Pharmaceuticals, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| US-12528828-B2 | Substituted pyrido[4,3-d]pyrimidines as KRAS modulators | ALTEROME THERAPEUTICS, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| EP-4667471-A2 | BROAD SPECTRUM ANTIVIRAL COMPOSITIONS AND METHODS | Evrys Bio, LLC (US) | 2025-12-24 | — | — | EP | disclosed |
| US-20250353818-A1 | Compounds | Psylo Pty Ltd (AU) | 2025-11-20 | — | — | US | disclosed |
| CN-1321153-A | telomerase inhibitors and methods of use thereof | GERON CORP (US) | 2001-11-07 | — | — | CN | disclosed |
| WO-2001002377-A9 | TELOMERASE INHIBITORS AND METHODS OF THEIR USE | GERON CORP (US) | 2001-10-11 | — | — | WO | disclosed |
| EP-1140924-A1 | PIPERAZINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-10-10 | — | — | EP | disclosed |
| EP-1109796-A1 | TELOMERASE INHIBITORS AND METHODS OF THEIR USE | Geron Corporation (US) | 2001-06-27 | — | — | EP | disclosed |
| WO-2001002377-A1 | TELOMERASE INHIBITORS AND METHODS OF THEIR USE | GERON CORPORATION (US) | 2001-01-11 | — | — | WO | disclosed |
| WO-2000035915-A1 | PIPERAZINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-06-22 | — | — | WO | disclosed |
| US-5843983-A | Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use | SANKYO COMPANY, LIMITED (JP) | 1998-12-01 | — | — | US | disclosed |
| CN-1174190-A | Diaryl alkane derivatives containing alicyclic group, their preparation and their therapeutic and prophylactic uses | SANKYO CO (JP) | 1998-02-25 | — | — | CN | disclosed |
| EP-0790235-A1 | Diaryl alkane derivatives containing an alicyclic group, their preparation and their therapeutic and prophylactic uses | SANKYO COMPANY LIMITED (JP) | 1997-08-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092059-A1 | Broad Spectrum Antiviral Compositions and Methods | IRF3, ZC3HAV1, ZC3HAV1L | ALDH1A1 3002/4885TSHR 682/4885HPGD 4778/4885 |
| US-12528828-B2 | Substituted pyrido[4,3-d]pyrimidines as KRAS modulators | KRAS, NRAS, HRAS | ALDH1A1 1854/4885TSHR 263/4885HPGD 2903/4885 |
| US-20250353818-A1 | Compounds | NLN, SLC18A2, PYGB | ALDH1A1 981/4885TSHR 1561/4885HPGD 694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.